Andrew Sproul PhD

Dr. Andrew Sproul is the founding Director of the Stem Cell and Cellular Models Platform at the Taub Institute for Research on Alzheimer's Disease and the Aging Brain, a proactive resource established to provide access to human pluripotent stem cell technology for neurodegenerative and neurological disease researchers at Columbia University. Prior to pursuing his graduate studies, Dr. Sproul trained with Sir Hans Kornberg at Boston University and helped elucidate novel fructose metabolic pathways in E. Coli. He received his Ph.D. in Biological Sciences at Columbia University under the tutelage of Dr. Lloyd Greene, where his studies focused on the regulation of the JNK signaling pathway in neuronal cell death. After a short postdoc at the Icahn School of Medicine at Mt Sinai with Dr. Sergei Sokol studying neuronal development, he worked at The New York Stem Cell Foundation for 5 years, where he ran the day-to-day operations of a variety of collaborative Alzheimer's iPSC projects under Dr. Scott Noggle.